Related Experiment Video
Updated: May 7, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and
Wenjing Li1, Yajun Shen2, Lingyu Li3
1Beijing Institute of Dental Research, Beijing Stomatological Hospital and School of Stomatology, Capital Medical University, Beijing, China.
Introduction:
Oral leukoplakia (OLK) is a prevalent oral potentially malignant disorder with limited treatment options. Our previous research showed that Azoxystrobin (AZOX) induces apoptosis and inhibits mitochondrial complex III activity. Peroxiredoxin 1 (Prx1) plays an important role in OLK progression, and preliminary evidence suggests AZOX may target Prx1 to disrupt mitochondrial function. This study aims to elucidate the precise molecular mechanism by investigating AZOX's interaction with specific Prx1 residues.
Methods:
We employed AutoDock Vina for molecular docking to predict AZOX-Prx1 interactions. Using seamless cloning, Prx1-WT, Prx1-Trp87 mutant, and Prx1-Thr90 mutant variants were constructed and expressed in DOK and Leuk1 OLK cell lines. Comprehensive assessments included cell viability (Cell Counting Kit-8, CCK-8), apoptosis (flow cytometry), mitochondrial ultrastructure (transmission electron microscopy, TEM), mitochondrial ROS (mtROS) production, membrane potential (MMP), complex III activity, cellular energy metabolism (mitochondrial stress assay), and expression of mitochondrial apoptosis-related proteins (Western blot/immunofluorescence).
Results:
Molecular docking revealed AZOX forms four hydrogen bonds with the Gln94, Thr90, and Thr49 residues of Prx1 and engages in π-π interaction with Trp87. AZOX treatment significantly inhibited cell proliferation and activated mitochondrial apoptosis, evidenced by increased Bax/Bcl-2 ratio and Cytochrome C (Cyto C) release, which was accompanied by comprehensive mitochondrial dysfunction including structural damage, complex III suppression, elevated mtROS, reduced MMP, and inhibited energy metabolism. Critically, both Trp87 and Thr90 mutations substantially attenuated AZOX's effects on mitochondrial integrity and apoptotic induction.
Conclusion:
AZOX may bind to the Trp87 and Thr90 sites of Prx1 to inhibit mitochondrial function and energy metabolism, and induce mitochondria-mediated apoptosis, thereby suppressing the progression of OLK.
Insights
Azoxystrobin (AZOX) targets Peroxiredoxin 1 (Prx1) at specific sites, inhibiting mitochondrial function and inducing apoptosis in oral leukoplakia (OLK) cells. This mechanism offers a potential therapeutic strategy for this pre-malignant oral disorder.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Oral leukoplakia (OLK) is a significant oral potentially malignant disorder with limited therapeutic interventions.
- Peroxiredoxin 1 (Prx1) is implicated in OLK progression, and Azoxystrobin (AZOX) has shown potential in targeting mitochondrial function.
Purpose of the Study:
- To elucidate the precise molecular mechanism by which AZOX interacts with Peroxiredoxin 1 (Prx1) to inhibit mitochondrial function and induce apoptosis in OLK.
- To investigate the role of specific Prx1 residues (Trp87 and Thr90) in mediating AZOX's effects.
Main Methods:
- Molecular docking (AutoDock Vina) was used to predict AZOX-Prx1 interactions.
- Site-directed mutagenesis was employed to create Prx1-Trp87 and Prx1-Thr90 mutants.
- Experiments in OLK cell lines (DOK, Leuk1) assessed cell viability, apoptosis, mitochondrial ultrastructure, ROS production, membrane potential, complex III activity, energy metabolism, and protein expression.
Main Results:
- Molecular docking identified key interactions between AZOX and Prx1 residues, including hydrogen bonds with Gln94, Thr90, Thr49, and π-π interaction with Trp87.
- AZOX treatment significantly reduced OLK cell proliferation and induced mitochondrial apoptosis, characterized by altered Bax/Bcl-2 ratio and Cytochrome C release.
- Mutations at Trp87 and Thr90 residues of Prx1 attenuated AZOX's inhibitory effects on mitochondrial integrity and apoptosis induction.
Conclusions:
- AZOX exerts its anti-cancer effects by binding to Trp87 and Thr90 residues of Prx1, leading to mitochondrial dysfunction and apoptosis.
- This interaction suppresses mitochondrial function, energy metabolism, and promotes apoptosis, offering a novel therapeutic avenue for oral leukoplakia.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Extrinsic Apoptotic Pathway
Apoptosis
Antifungal Agents
